risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. “Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1RA initiation linked to new
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1RA initiation linked to new](https://www.news-medical.net/images/news/ImageForNews_800978_17380318361188691.jpg)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1RA initiation linked to new](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2025/08/15/16/24/glp-1ra-767x535.jpg)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1RA initiation linked to new](https://cdn.sanity.io/images/0vv8moc6/educated-patient/0a81ec581f540b03cabac11dee4d379322238b58-1468x1476.png)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) GLP-1RA initiation linked to new](https://www.mdpi.com/biomolecules/biomolecules-14-00687/article_deploy/html/images/biomolecules-14-00687-g001.png)
























